Global Bipolar Disorder Therapeutics Market Report 2024

Bipolar Disorder Therapeutics Global Market Report 2024 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Bipolar Disorder Therapeutics Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Bipolar Disorder Therapeutics Market Definition And Segments

Bipolar disorder therapeutics refer to medication, including mood stabilizers, antidepressants, antipsychotics, and psychological counseling, to control symptoms. The bipolar disorder therapeutic is used in the treatment and management of bipolar disorders.

The main types of drugs in bipolar disorder therapeutics are mood stabilizers, antipsychotic drugs, antidepressant drugs, and other drugs. Mood stabilizers refer to a class of medications used in the management and treatment of bipolar disorders. The different mechanisms include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta-blockers, and others. These are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The bipolar disorder therapeutics market covered in this report is segmented –

1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs

2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The bipolar disorder therapeutics market size has grown strongly in recent years. It will grow from $7.09 billion in 2023 to $7.53 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rise in medical research and developments, increased healthcare expenditure, rise in prevalence of mental health disorders, rise in patient advocacy.

The bipolar disorder therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.46 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing prevalence of bipolar disorder, government initiatives, expansion of healthcare infrastructure, growing adoption of a sedentary lifestyle. Major trends in the forecast period include personalized treatment approaches, digital health integration, innovative medications, preventive interventions, neuroimaging and biomarkers.

A Lifelong Condition That Requires Early Diagnosis And Proper Treatment

The increase in the prevalence of bipolar disorder is expected to propel the growth of the bipolar disorder therapeutics market going forward. Bipolar disorder refers to a disabling illness that is associated with depressive mood swings and includes symptoms such as irregular sleep, low motivation, and loss of interest in daily activities. Population growth and aging are leading to an increase in the burden of bipolar disorder over time. As a result, an increase in the prevalence of bipolar disorder increases the demand for the bipolar disorder therapeutics market. For instance, according to the Depression and Bipolar Support Alliance, a US-based non-profit association providing support to the patients of depression or bipolar disorder, in 2021, approximately 5.7 million adult Americans which was about 2.6% of the U.S. population were affected by bipolar disorder. The median age of the onset of bipolar disorder is 25 years, and more than two-thirds of people suffering from bipolar disorder had at least one relative with the illness. Therefore, the increase in the prevalence of bipolar disorder is driving the growth of the bipolar disorder therapeutics market.

Increasing Demand For Psychological Counseling Drives Growth Of Bipolar Disorder Therapeutics Market

Increasing demand for psychological counseling is expected to propel the growth of the bipolar disorder therapeutics market going forward. One sort of therapy that tries to assist people in overcoming mental health issues and enhancing their quality of life is psychological counselling. Psychotherapy can assist in managing bipolar illness symptoms and determining the factors that set off bipolar episodes. It can also assist people in learning useful coping mechanisms for stressful situations. For instance, in September 2022, according to The Centers for Disease Control and Prevention (CDC), from 2019 to 2021, the percentages of men (from 13.1% to 17.8%) and women (from 23.8% to 28.6%) aged 18–44 who had received any mental health treatment in the past 12 months increased in the U.S. Therefore, increased psychological counselling demand drives the bipolar disorder therapeutics market.

Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd., H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan PLC, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.

Strategic Partnerships Driving Growth In The Bipolar Disorder Therapeutics Market

Strategic partnerships have emerged as a key trend gaining popularity in the bipolar disorder therapeutics market. Major companies operating in the bipolar disorder therapeutics sector are focused on partnerships to reinforce their position. For instance, in October 2021, Mindpax Inc., a Germany-based digital technology company operating in the bipolar disorder therapeutics market, partnered with Eversana Life Science Services LLC, a US-based life sciences company operating in the bipolar disorder therapeutics market. Through this partnership, both companies will develop remote clinical assessments and targeted digital therapy to improve patients' clinical conditions and provide personalized therapeutic interventions to bipolar patients. Furthermore, in November 2020, Biogen, a US-based biotechnology company, partnered with Sage Therapeutics, a US-based company that develops novel therapies including bipolar. Through this partnership, both businesses will work together to commercialize zuranolone (SAGE-217) for significant postpartum depression (PPD), depressive disorder (MDD), and other psychiatric diseases.

The Rise Of Novel Therapies For Bipolar Disorders

Major companies operating in the Bipolar Disorder Therapeutics and related market are developing new treatment for depressive episodes associated with bipolar I or II disorder to meet larger customer bases, more sales, and increase revenue. Among bipolar disorders, bipolar depression is the most prevalent and severe clinical manifestation. If compared to manic/hypomanic episodes, these depressed episodes are linked to a poorer prognosis, longer duration, and more recurrences. For instance, in December 2021, Intra-Cellular Therapies, Inc. (ITCI), a US based a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders, announced U.S FDA approved for ‘CAPLYTA’ medication in treating the depressive episodes associated with bipolar I or II disorder in adults, as monotherapy and as adjunctive therapy with lithium or valproate.

Neuraxpharm's Expansion With Lazap In Europe

In June 2023, Brain Therapeutics, a Greece-based central nervous system specialty company, acquired the prescription drug brand Lazap (olanzapine) from the Greek pharmaceutical company Lyofin Ltd for an undisclosed amount. The acquisition enables Neuraxpharm Group to expand its therapeutic product portfolio in Greece and Europe. This agreement aims to extend Neuraxpharm's reach in Greece and harness its deep expertise in the central nervous system (CNS) to offer the right products from its extensive lineup to CNS patients, healthcare professionals, pharmacists, and hospitals across Greece, effectively meeting the healthcare demands of patients in the country. Lyofin Ltd. is a Greece-based pharmaceutical company.

North America was the largest region in the bipolar disorder therapeutics market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bipolar disorder therapeutics market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bipolar disorder therapeutics market includes revenues earned by entities by family-focused therapy, interpersonal and social rhythm therapy, cognitive behavioral therapy and dialectical behavior therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The bipolar disorder therapeutics market research report is one of a series of new reports from The Business Research Company that provides bipolar disorder therapeutics market statistics, including bipolar disorder therapeutics industry global market size, regional shares, competitors with a bipolar disorder therapeutics market share, detailed bipolar disorder therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder therapeutics industry. This bipolar disorder therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bipolar Disorder Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $7.53 billion
Revenue Forecast In 2033 $9.46 billion
Growth Rate CAGR of 5.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled AbbVie Inc.; Pfizer Inc.; Astellas Pharma Inc; AstraZeneca PLC; Bristol-Myers Squibb; GlaxoSmithKline PLC; Januaryssen Pharmaceuticals; Novartis AG; Otsuka Pharmaceutical Co. Ltd.; Validus Pharmaceuticals; Eli Lilly and Company; Gedeon Richter PLC.; Sumitomo Pharma Co. Ltd; H. Lundbeck A/S; Janssen Pharmaceuticals; Sanofi S.A.; Lundbeck A/S; Allergan plc; Takeda Pharmaceutical Company Limited; Sunovion Pharmaceuticals Inc.; Alkermes plc; Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Johnson & Johnson; Celon Pharma SA; NeuroRx Inc.; IntraCellular Therapies Inc.; Sumitomo Pharma Co. Ltd.; Vanda Pharmaceuticals Inc.; Sage Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Bipolar Disorder Therapeutics Market Characteristics

    3. Bipolar Disorder Therapeutics Market Trends And Strategies

    4. Bipolar Disorder Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Bipolar Disorder Therapeutics Market Size and Growth

    5.1. Global Bipolar Disorder Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Bipolar Disorder Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Bipolar Disorder Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Bipolar Disorder Therapeutics Market Segmentation

    6.1. Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Mood Stabilizers

    Antipsychotic Drugs

    Antidepressant Drugs

    Other Drugs

    6.2. Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Selective Serotonin Reuptake Inhibitors

    Serotonin-norepinephrine Reuptake Inhibitors

    Tricyclic Antidepressants

    Monoamine Oxidase Inhibitors

    Benzodiazepines

    Beta-Blockers

    Other Mechanisms

    6.3. Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Bipolar Disorder Therapeutics Market Regional And Country Analysis

    7.1. Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Bipolar Disorder Therapeutics Market  

    8.1. Asia-Pacific Bipolar Disorder Therapeutics Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Bipolar Disorder Therapeutics Market  

    9.1. China Bipolar Disorder Therapeutics Market Overview  

    9.2. China Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Bipolar Disorder Therapeutics Market  

    10.1. India Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Bipolar Disorder Therapeutics Market  

    11.1. Japan Bipolar Disorder Therapeutics Market Overview  

    11.2. Japan Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Bipolar Disorder Therapeutics Market  

    12.1. Australia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Bipolar Disorder Therapeutics Market  

    13.1. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Bipolar Disorder Therapeutics Market  

    14.1. South Korea Bipolar Disorder Therapeutics Market Overview  

    14.2. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Bipolar Disorder Therapeutics Market  

    15.1. Western Europe Bipolar Disorder Therapeutics Market Overview

    15.2. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Bipolar Disorder Therapeutics Market  

    16.1. UK Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Bipolar Disorder Therapeutics Market  

    17.1. Germany Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Bipolar Disorder Therapeutics Market  

    18.5. France Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Bipolar Disorder Therapeutics Market  

    19.9. Italy Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Bipolar Disorder Therapeutics Market  

    20.13. Spain Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Bipolar Disorder Therapeutics Market  

    21.1. Eastern Europe Bipolar Disorder Therapeutics Market Overview

    21.2. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Bipolar Disorder Therapeutics Market  

    22.1. Russia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Bipolar Disorder Therapeutics Market  

    23.1. North America Bipolar Disorder Therapeutics Market Overview

    23.2. North America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Bipolar Disorder Therapeutics Market  

    24.1. USA Bipolar Disorder Therapeutics Market Overview

    24.2. USA Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Bipolar Disorder Therapeutics Market  

    25.1. Canada Bipolar Disorder Therapeutics Market Overview

    25.2. Canada Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Bipolar Disorder Therapeutics Market  

    26.1. South America Bipolar Disorder Therapeutics Market Overview

    26.2. South America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Bipolar Disorder Therapeutics Market  

    27.1. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Bipolar Disorder Therapeutics Market  

    28.1. Middle East Bipolar Disorder Therapeutics Market Overview

    28.2. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Bipolar Disorder Therapeutics Market  

    29.1. Africa Bipolar Disorder Therapeutics Market Overview

    29.2. Africa Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Bipolar Disorder Therapeutics Market Competitive Landscape

    30.2. Bipolar Disorder Therapeutics Market Company Profiles

    30.2.1. AbbVie Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Astellas Pharma Inc

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AstraZeneca PLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bristol-Myers Squibb

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Bipolar Disorder Therapeutics Market Competitive Benchmarking

    32. Global Bipolar Disorder Therapeutics Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market

    34. Bipolar Disorder Therapeutics Market Future Outlook and Potential Analysis

    34.1 Bipolar Disorder Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    34.2 Bipolar Disorder Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    34.3 Bipolar Disorder Therapeutics Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: AbbVie Inc. Financial Performance
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Astellas Pharma Inc Financial Performance
  • Table 77: AstraZeneca PLC Financial Performance
  • Table 78: Bristol-Myers Squibb Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: AbbVie Inc. Financial Performance
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Astellas Pharma Inc Financial Performance
  • Figure 77: AstraZeneca PLC Financial Performance
  • Figure 78: Bristol-Myers Squibb Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the biosurfactantsmarket?

The term ‘biosurfactant’ refers to a diverse group of molecules, which consist of a polar head (hydrophilic) and a non-polar tail (hydrophobic). They are produced by various microorganisms, which include Acinetobacter sp., Bacillus sp., Candida antartica, and Pseudomonas aeruginosa. They can be used to replace synthetic surfactants in a variety of industrial processes, including lubrication, wetting, softening, fixing dyes, making emulsions, stabilizing dispersions, foaming, and preventing foaming, as well as in the food, biomedical, and pharmaceutical industries, and organic bioremediation. For further insights on the biosurfactants market, request a sample here

How will the biosurfactants market drivers and restraints affect the biosurfactants market dynamics? What forces will shape the biosurfactants industry going forward?

The biosurfactants market major growth driver - biosurfactants market a growing demand in personal care industries. For further insights on the biosurfactants market, request a sample here

What is the forecast market size or the forecast market value of the biosurfactants market ?

The biosurfactants market size has grown strongly in recent years. It will grow from $4.44 billion in 2023 to $4.85 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growth in pharmaceuticals industry, rise in demand for cosmetics, rise in environmental concerns, increased demand for eco-friendly solutions, emerging markets. The biosurfactants market size is expected to see strong growth in the next few years. It will grow to $6.87 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing research and development activities, shift towards clean energy, increasing demand from the agriculture industry, rise in disposable income. Major trends in the forecast period include tailored biosurfactants, bioremediation applications, collaborations and partnerships, antimicrobial biosurfactants, carbon footprint reduction. For further insights on the biosurfactants market, request a sample here

How is the biosurfactants market segmented?

The biosurfactants market is segmented
1) By Product Type: Glycolipid, Phospholipids, Surfactin, Lichenysin, Polymeric Bio-surfactants, Other Product Types
2) By Application: Detergents, Personal Care, Food Processing, Agricultural Chemicals, Other ApplicationsFor further insights on the biosurfactants market,
request a sample here

Which region has the largest share of the biosurfactants market? What are the other regions covered in the report?

Western Europe was the largest region in the biosurfactants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosurfactants market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the biosurfactants market, request a sample here.

Who are the major players in the biosurfactants market?

Major companies operating in the biosurfactants market include AGAE Technologies, Biotensidon GmbH, Croda International plc, Dispersa Inc., Evonik Industries AG, GlycoSurf Inc., Holiferm Ltd., Jeneil Biotech Inc., Kemin Industries Inc., Lion Corporation, Rhamnolipid, Saraya Mystair Hygiene Pvt. Ltd., Stepan Company, TensioGreen Corp., Victex plc, AlgaEnergy, Al Zaabi Group, Inse India AquaFUELs Pvt Ltd, Biotrem Labs, Diversey Holdings Ltd., Ecover Group, GEA Group, Global Green Chemicals Public Company Limited, Glyconova, Innospec Inc., Lipofoods, Locus Fermentation Solutions, Metgen Oy, MG Intobio Co. Ltd., Oqema Group, Procter & Gamble, R-Biopharm AG For further insights on the biosurfactants market, request a sample here.

What are the key trends in the biosurfactants market?

Major trend in the biosurfactants market - technological development driving growth in biosurfactant market. For further insights on the biosurfactants market, request a sample here.

What are the major opportunities in the biosurfactants market? What are the strategies for the biosurfactants market?

For detailed insights on the major opportunities and strategies in the biosurfactants market, request a sample here.

How does the biosurfactants market relate to the overall economy and other similar markets?

For detailed insights on biosurfactants market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the biosurfactants industry?

For detailed insights on the mergers and acquisitions in the biosurfactants industry, request a sample here.

What are the key dynamics influencing the biosurfactants market growth? SWOT analysis of the biosurfactants market.

For detailed insights on the key dynamics influencing the biosurfactants market growth and SWOT analysis of the biosurfactants industry, request a sample here.